Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
M. Bringas Beranek
Observed names:
M. Bringas,
Marianela Bringas,
Marianela Bringas Beranek,
Marianela Bringas-Beranek
Institutions:
Hospital General Universitario Gregorio Marañón,
Instituto de Investigación Sanitaria Gregorio Marañón
Observed institutions:
Universidad Complutense de Madrid,
Hospital General Universitario Gregorio Marañón,
Instituto de Investigación Sanitaria Gregorio Marañón
ORCID:
0000-0001-8266-705X
Observed ORCID:
0000-0001-8266-705X
OpenAlex ID:
A5014802509
Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid
2020
·
Antonio Calles
, María Inmaculada Aparicio
, et al.
·
Frontiers in Oncology
·
36
PDF
Incidence of venous thromboembolism in patients with colorectal cancer according to oncogenic status
2020
·
L. Ortega Morán
, P. García Alfonso
, et al.
·
Clinical & Translational Oncology
·
17
Analysis of survival trends, clinical, and molecular characteristics of patients with early-onset colorectal cancer (EOCRC).
2022
·
Javier Soto
, Natalia Gutiérrez Alonso
, et al.
·
Journal of Clinical Oncology
·
5
Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer
2023
·
Inmaculada Aparicio
, Patricia Iranzo
, et al.
·
Thrombosis Research
·
4
PDF
Iatrogenic hyperthyroidism can be a triggering factor for takotsubo cardiomyopathy
2019
·
Eva Cervilla-Muñoz
, Marianela Bringas-Beranek
, et al.
·
Medicina Clínica
·
3
Impact of COVID-19 in continuity ofcancer treatment for lung cancer patients
2020
·
Antonio Calles
, Manuel Alva
, et al.
·
Clinical Cancer Research
·
2
Incidence of venous thromboembolic disease (VTE) in a cohort of patients with colorectal cancer (CRC) according to KRAS, NRAS and BRAF status.
2019
·
Pilar Garcia-Alfonso
, Laura Ortega Morán
, et al.
·
Journal of Clinical Oncology
·
2
Antitumor activity of the combination of vinorelbine and gemcitabine in patients with HR + /HER2- advanced breast cancer after CDK4/6 inhibitor
2025
·
Pablo Jara
, Marc Ariant
, et al.
·
Breast Cancer Research and Treatment
·
1
Ovarian Toxicity Linked to Early-stage Breast Cancer Treatment
2024
·
Isabel Echavarria
, Yolanda Jerez
, et al.
·
Journal of young women's breast cancer and health.
·
1
1648P Association between circulating tumor cell count and thrombosis in pancreatic cancer
2023
·
M. Benavente
, N. Gutierrez Alonso
, et al.
·
Annals of Oncology
·
1
PDF
Abstract P3-01-04: A real-world evidence study of everolimus plus endocrine therapy beyond CDK4/6 inhibitors for HR+/HER2- advanced breast cancer
2023
·
Rodrigo Sánchez-Bayona
, Manuel Alva
, et al.
·
Cancer Research
·
1
Clinical and survival characteristics of patients with BRAF-mutated metastatic colorectal cancer (mCRC) who receive metastases surgery in a Spanish cohort.
2023
·
Javier Soto
, Marianela Bringas
, et al.
·
Journal of Clinical Oncology
·
1
Clinical evolution after surgery of hepatic metastases of colorectal cancer according to genomic profile.
2022
·
Blanca Morón García
, Manuel Alva Bianchi
, et al.
·
Journal of Clinical Oncology
·
1
Abstract PO-031: Outcomes of COVID-19 in patients with lung cancer treated in a tertiary hospital in Madrid
2020
·
Antonio Calles
, Inmaculada Aparicio
, et al.
·
Clinical Cancer Research
·
1
Abstract PO-021: Impact of COVID-19 in continuity of cancer treatment for lung cancer patients
2020
·
Antonio Calles
, Manuel Alva
, et al.
·
Clinical Cancer Research
·
1
Abstract PO-036: Safety outcomes of resuming anticancer treatment in patients with lung cancer affected by COVID-19 illness
2020
·
Antonio Calles
, Mar Galera
, et al.
·
Clinical Cancer Research
·
1
Metastases resection in colorectal cancer patients with mutation in oncogene BRAF or tumors located on the right side: Experience at the HGUGM.
2020
·
Laura Ortega
, Marianela Bringas Beranek
, et al.
·
Journal of Clinical Oncology
·
1
Mainstream and fast-track genetic testing in pancreatic cancer patients and its impact on treatment: our experience in a tertiary hospital in Spain
2026
·
M. Bringas
, I. Echavarría
, et al.
·
Familial Cancer
2953eP Risk factors and incidence of thromboembolic events in patients with locally advanced or metastatic melanoma receiving systemic therapy: a retrospective observational study
2025
·
G. Hernandez Torrado
, J. Soto Alsar
, et al.
·
Annals of Oncology
2264eP Impact of mainstream genetic testing on the decision-making process of pancreatic cancer patients
2025
·
M. Bringas Beranek
, I. Echavarria Diaz-Guardamino
, et al.
·
Annals of Oncology
27P Study of tumor mutational variation measured by NGS in patients with BRAF-mutated metastatic colorectal cancer undergoing surgery after prior systemic treatment
2025
·
J. Soto Alsar
, M. Del Monte-Millan
, et al.
·
Annals of Oncology
PDF
394 Mutated NBN gene in patients within hereditary gynaecological cancer unit
2024
·
Andrea Fraile López
, María Fernández Muñoz
, et al.
·
International Journal of Gynecological Cancer
497 Patients with RAD51C and RAD51D mutation followed up in a hereditary gynaecological cancer unit
2024
·
María Fernández Muñoz
, Andrea Fraile López
, et al.
·
International Journal of Gynecological Cancer
Clinical characteristics and survival analysis in patients with isolated pulmonary metastases from colorectal cancer (CRC).
2024
·
Javier Soto Alsar
, Roberto Jiménez Rodríguez
, et al.
·
Journal of Clinical Oncology
PDF
Survival benefit and clinical characteristics of patients with metastatic colorectal cancer (mCRC) receiving pulmonary metastasectomy.
2024
·
Javier Soto Alsar
, Roberto Jiménez Rodríguez
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
41
Citation count:
79
H-index:
4
I10-index:
2
Year
Topic
Type